SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Ries LAG,Melbert D,Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004. Bethesda, MD: National Cancer Institute; Year. Available at URL: http://seer.cancer.gov/csr/1975_2004/ based on November 2006 SEER data submission, posted to the SEER website, 2007. Published in 2007.
  • 2
    Munoz N,Castellague X,de Gonzalez AB,Gizzmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006; 24( suppl 3): s1s10.
  • 3
    Parkin DM,Bray F. The burden of HPV-related cancers. Vaccine. 2006; 24( suppl 3): S3-11S3/25.
  • 4
    Stuver S,Adami H. Cervical cancer. In: Textbook of Cancer Epidemiology. Oxford: Oxford University Press; 2002.
  • 5
    Mould RF,Barrett A. New primary cancers in patients originally presenting with carcinoma of the cervix. Br J Obstet Gynaecol. 1976; 83: 8185.
  • 6
    Clarke EA,Kreiger N,Spengler RF. Second primary cancer following treatment for cervical cancer. CMAJ. 1984; 131: 553556.
  • 7
    Kleinerman RA,Boice JDJr,Storm HH, et al. Second primary cancer after treatment for cervical cancer. An international cancer registries study. Cancer. 1995; 76: 442452.
  • 8
    Fisher G,Harlow SD,Schottenfeld D. Cumulative risk of second primary cancer in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985-1992. Gynecol Oncol. 1997; 64: 213223.
  • 9
    Kleinerman RA,Kosary C,Hildesheim A. New malignancies following cancer of the cervix uteri, vagina, and vulva. In: New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. NIH Pub. No. 05-5302. Bethesda, MD: National Cancer Institute; 2006: 207229.
  • 10
    Chaturvedi AK,Engels EA,Gilbert ES, et al. Second cancers among 104760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst. 2007; 99: 16341643.
  • 11
    Rambout L,Hopkins L,Hutton B,Fergusson D. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ. 2007; 177: 469479.
  • 12
    Dillner J,Arbyn M,Dillner L. Translational mini-series on vaccines: monitoring of human papillomavirus vaccination. Clin Exp Immunol. 2007; 148: 199207.
  • 13
    Kahn JA,Lan D,Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol. 2007; 110: 8795.
  • 14
    JohnsonCH, ed. SEER Program Coding and Staging Manual 2004. Revision 1. NIH Pub. No. 04-5581. Bethesda, MD: National Cancer Institute; 2004.
  • 15
    Watson M, Saraiya M, Ahmed F, et al. Using population-based registry data to assess the burden of HPV-associated cancers in the United States: overview of methods. Cancer. 2008; 113(10 suppl ): 28412854.
  • 16
    National Cancer Institute. SEER Incidence Site Recode. Bethesda, MD: National Cancer Institute; Year. Available at:http://seer.cancer.gov/siterecode/icdo3_d01272003/. Accessed January 24, 2008. Published in 2008.
  • 17
    Ahmed F,Goodman MT,Kosary C, et al. Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001. Cancer. 2006; 107(5 suppl): 11621171.
  • 18
    National Cancer Institute. Surveillance Research Program SEER*STAT software [computer program]. Version 6.1.4. Bethesda, MD: National Cancer Institute; 2005. Available at: www.seer.cancer.gov/seerstat. Accessed on January 24, 2008.
  • 19
    Boice JDJr. Ionizing radiation. In: SchottenfeldD,FraumeniJFJr, eds.Cancer Epidemiology and Prevention.3rd ed. New York: Oxford University Press; 2006: 259293.
  • 20
    Thompson B,Coronado G,Neuhouser M,Chen L. Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting. Cancer. 2005; 103: 24912498.
  • 21
    Winkleby MA,Snider J,Davis B,Jennings MG,Ahn DK. Cancer-related health behaviors and screening practices among Latinos: findings from a community and agricultural labor camp survey. Ethn Dis. 2003; 13: 376386.
  • 22
    Castellsague X,Munoz N. Chapter 3: cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003;( 31): 2028.
  • 23
    Plummer M,Herrero R,Franceschi S, et al. Smoking and cervical cancer: pooled analysis of the IARC multicentric case-control study. Cancer Causes Control. 2003; 14: 805814.
  • 24
    Demark-Wahnefried W,Aziz NM,Rowland JH,Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005; 23: 58145830.
  • 25
    Gritz ER,Fingeret MC,Vidrine DJ,Lazev AB,Mehta NV,Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006; 106: 1727.